Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019008604) NOVEL FORMS OF MU-OPIOID RECEPTOR AGONIST
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/008604 International Application No.: PCT/IN2018/050440
Publication Date: 10.01.2019 International Filing Date: 07.07.2018
IPC:
C07D 233/64 (2006.01) ,A61P 1/12 (2006.01) ,A61K 31/417 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
233
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
54
having two double bonds between ring members or between ring members and non-ring members
64
with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1
Drugs for disorders of the alimentary tract or the digestive system
12
Antidiarrhoeals
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
4164
1,3-Diazoles
417
Imidazole-alkylamines, e.g. histamine, phentolamine
Applicants:
CIPLA LIMITED [IN/IN]; Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai, Maharashtra 400013, IN
Inventors:
PHULL, Manjinder Singh; IN
RAO, Dharmaraj Ramachandra; IN
MALHOTRA, Geena; IN
THOPPIL, Sanoj Jose; IN
TARATE, Sagar Narayan; IN
CHAUGULE, Hanmant Nagnath; IN
Agent:
P., Aruna Sree; IN
Priority Data:
20172102401307.07.2017IN
20172103652913.10.2017IN
Title (EN) NOVEL FORMS OF MU-OPIOID RECEPTOR AGONIST
(FR) NOUVELLES FORMES D'AGONISTE DU RÉCEPTEUR MU-OPIOÏDE
Abstract:
(EN) The present invention discloses novel polymorphs of 5-[[[(2S)-2-amino-3-[4- (aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H- imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid and its pharmaceutically acceptable salts.
(FR) L'invention concerne de nouveaux polymorphes d'acide 5-[[[(2S)-2-amino-3-[4-(aminocarbonyl)-2,6-diméthylphényl]-1-oxopropyl][(1S)-1-(4-phényl-1-H-imidazol-2-yl)éthyl]amino]méthyl]-2-méthoxybenzoïque, et ses sels pharmaceutiquement acceptables.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)